Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2012
12/27/2012US20120328659 Treatment of streptococcal infections
12/27/2012US20120328658 Compositions and methods for vaccinating against hsv-2
12/27/2012US20120328657 Compositions and methods for vaccinating against hsv-2
12/27/2012US20120328656 Compositions and methods for vaccinating against hsv-2
12/27/2012US20120328654 Multi-phase emulsions based on amphiphilic block copolymers
12/27/2012US20120328652 Recombinant attenuated parvovirus
12/27/2012US20120328650 Modified vaccinia ankara virus variant
12/27/2012US20120328644 Low Antigen-dose Immunization for Maximizing T-helper Cell 1 (Th1) Immunity Against a Pathogen
12/27/2012US20120328643 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
12/27/2012US20120328642 Botulinum neurotoxin antigenic compositions and methods
12/27/2012US20120328641 Conformationally stabilized hiv envelope immunogens
12/27/2012US20120328635 Chaperonin 10 variants
12/27/2012US20120328632 Inhibition of leukocyte adhesion
12/27/2012US20120328628 Antibodies to conformationally trapped proteins
12/27/2012US20120328627 Chemokine receptor antagonists and use thereof
12/27/2012US20120328626 Method for increasing n-glycosylation site occupancy on therapeutic glycoproteins produced in pichia pastoris
12/27/2012US20120328586 Methods and means for protecting the skin against pathogenic microorganisms
12/27/2012US20120328576 Defined dose therapeutic phage
12/27/2012US20120328572 Bacillus bacteria for use in treating and preventing infection in aquatic animals
12/27/2012US20120328571 Method for Using a Bacillus Subtilis Strain for Prophylaxis and Treatment of Gastro-Intestinal Conditions
12/27/2012US20120328570 Hepatitis C Virus Inhibitors
12/27/2012US20120328569 Inhibitors of hepatitis c virus ns5b polymerase
12/27/2012US20120328568 Compositions and uses of lectins
12/27/2012US20120328565 Antiviral compounds
12/27/2012US20120328564 Camptothecin-Binding Moiety Conjugates
12/27/2012US20120328563 Cd4+cd25+ regulatory t cells from human blood
12/27/2012US20120328555 Drug delivery of temozolomide for systemic based treatment of cancer
12/27/2012US20120328553 Method and antibacterial/antimicrobial compositions in dental compositions
12/27/2012US20120328544 Dermatological Treatment Methods And Formulations
12/27/2012US20120328543 Use of a cationic, advantageously amphoteric, surfactant for the preparation of an antifungal solution that can be applied to the nail
12/27/2012US20120328540 Cysteinyl compounds, compositions and methods of use
12/27/2012US20120328539 Thickener Or Gellant For Oil Materials, Gel Composition Comprising Same, And Method Of Producing Cosmetic Material Or Topical Agent
12/27/2012US20120328537 Topical wound management formulation
12/27/2012US20120328534 Enzymatic peracid generation for use in oral care products
12/27/2012US20120328530 Toluidine blue derivatives as photosensitising compounds
12/27/2012US20120328525 Nanoparticle compositions and components thereof
12/27/2012US20120328517 Kallikrein-binding "kunitz domain" proteins and analogues thereof
12/27/2012CA2840376A1 Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites
12/27/2012CA2840215A1 Conjugate-based antifungal and antibacterial prodrugs
12/27/2012CA2840161A1 Method for amplifying nk cells
12/27/2012CA2839674A1 Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof
12/27/2012CA2839558A1 Leukotoxin e/d as a new anti-inflammatory agent and microbicide
12/27/2012CA2839554A1 Methods of treating and preventing staphylococcus aureus infections and associated conditions
12/27/2012CA2839473A1 Film-forming composition, and use thereof for treating herpes
12/27/2012CA2838912A1 Metalloenzyme inhibitor compounds
12/27/2012CA2834618A1 Hpv vaccine formulations comprising aluminum adjuvant and methods of producing same
12/26/2012EP2537830A1 Compounds and compositions as protein kinase inhibitors
12/26/2012EP2537530A1 Radiation therapy agent
12/26/2012EP2537520A1 Hepatics C therapies
12/26/2012EP2537514A1 Antimicrobial preparations having a content of octenidine dihydrochloride encapsulated in liposomes
12/26/2012EP2536838A2 Vectors expressing hiv antigens and gm-csf and related methods for generating an immune response
12/26/2012EP2536836A1 Antibody against serotype a lipopolysaccharide of pseudomonas aeruginosa
12/26/2012EP2536835A1 Antibody against serotype g lipopolysaccharide of pseudomonas aeruginosa
12/26/2012EP2536834A1 Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa
12/26/2012EP2536833A1 Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa
12/26/2012EP2536759A1 Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosa
12/26/2012EP2536734A1 Forms of rifaximin and uses thereof
12/26/2012EP2536720A1 Triazolo [4, 5 - b]pyridin derivatives
12/26/2012EP2536697A2 Novel antifungal triazole derivatives
12/26/2012EP2536696A1 Pyrimidine derivatives
12/26/2012EP2536427A1 Ic31 nanoparticles
12/26/2012EP2536411A2 Inhibitors of long and very long chain fatty acid metabolism as broad spectrum anti-virals
12/26/2012EP2536410A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
12/26/2012EP2536282A1 Methods for treating infection
12/26/2012CN202620297U Multi-tube ozone disinfection machine
12/26/2012CN102844330A Monoclonal antibody directed against the p17 protein of hiv, capable of neutralising the binding of p17 to the p17 receptor (p17r)
12/26/2012CN102844324A Methods for producing amino-substituted glycolipid compounds
12/26/2012CN102844318A Compounds for treating respiratory syncytial virus infections
12/26/2012CN102844315A Crystalline salts of a potent hcv inhibitor
12/26/2012CN102844305A Antibacterial isoquinolin-3-ylurea derivatives
12/26/2012CN102844041A New synergistic compositions for the treatment of topical viral infections
12/26/2012CN102844038A Mixture, dissolving solution and pharmaceutical agent each comprising thermophilic microorganism
12/26/2012CN102844032A Compound for treatment of respiratory condition or disease
12/26/2012CN102844028A Combination of a macrocyclic inhibitor of hcv, a non-nucleoside and a nucleoside
12/26/2012CN102844026A Fungal nail treatment composition
12/26/2012CN102839192A miRNA (micro Ribonucleic Acid) absorption carrier, preparation method and uses thereof
12/26/2012CN102839187A miR-29 absorption sequence, absorption carrier and uses thereof
12/26/2012CN102839183A Preparation method and application of recombinant enterovirus 71 type virus-like particle
12/26/2012CN102839160A Recombination influenza virus of high-efficiency expression HA (Hyaluronic Acid) protein, as well as preparation method and application thereof
12/26/2012CN102839159A CoxA16 virus strain and human CoxA16 inactivated vaccine
12/26/2012CN102839158A Canine distemper attenuated vaccine strain and medical purpose
12/26/2012CN102839157A MDCK cell system capable of stably coexpressing Hst3GIIV and beta1-4GalT1 and establishing method and application thereof
12/26/2012CN102839136A Lactobacillus johnsonii, and preparation and application thereof
12/26/2012CN102839108A Functional ginseng health care liquor and preparation method thereof
12/26/2012CN102839093A Chinese lizardtail herb health-care wine used for controlling beriberi
12/26/2012CN102839089A Saururus chinensis health wine for controlling beriberi
12/26/2012CN102839088A Mint health wine for relieving exterior syndrome and relieving wind heat
12/26/2012CN102838680A Helicobacter pylori multiple-epitope fusion protein and multiple-epitope vaccine prepared by helicobacter pylori multiple-epitope fusion protein
12/26/2012CN102838675A Ip-10 antibodies and their uses
12/26/2012CN102838671A Growth hormone with site-specific mutagenesis and site-specific decoration, preparation method and applications of growth hormone
12/26/2012CN102838661A Vancomycin or demethyl vancomycin analogue and medicinal uses thereof
12/26/2012CN102838623A Cefminox sodium compound crystal, preparation method of cefminox sodium compound crystal and sterile powder injection containing cefminox sodium compound crystal
12/26/2012CN102838621A (6R,7R)-3-methyl-7-[alpha-(N,N'-diisopropyl amidine thio)-acetylamino]-8-oxo-5-thia-1-azabicyclo[4,2,0]-oct-2-alkene-2-formic betaine crystals
12/26/2012CN102838596A Pyrrolo[2,3-b]pyridine derivative, preparation method and application thereof
12/26/2012CN102838571A Andrographolide derivative containing gamma-subunit butenolide, synthetic method and application thereof
12/26/2012CN102838549A New class of 1,5,6-substituted pyrimidine derivatives with anti-HIV virus effects
12/26/2012CN102838523A Anti-enterovirus 71 (EV71) valerolactam compounds, preparation method and uses thereof
12/26/2012CN102838485A Ilex latifolia thunb extract
12/26/2012CN102838460A Series of skin-whitening (lightening) compounds
12/26/2012CN102836441A Method for enhancing immune response in treatment of infectious and malignant disease
1 ... 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 ... 1798